// STATE LEGISLATION TRACKER

Missouri HB 838: Modifies provisions relating to abortion

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Missouri
Bill: HB 838
Filed: 2023-01-18
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Missouri HB838 appears to be an abortion-related bill, not a peptide, compounding, telehealth, or prescribing bill. Based on the title and available summary, it does not appear to change access to compounded peptides, off-label prescribing, NP/naturopathic scope, FDA 503A/503B rules, controlled substances, or prescription monitoring.

Key Points

No visible change to peptide prescribing or access.
No apparent change to compounded peptide rules.
No apparent telehealth or PDMP impact.
No apparent NP or naturopathic scope change.

What to Watch For

Note Relevant mainly to reproductive-care counseling, not peptide access.

Note No FDA 503A/503B, controlled-substance, or PDMP language is apparent from the title and summary.

Note Clinicians should separate abortion-law compliance from routine peptide prescribing workflows.

Where the Bill Stands

The last available action shows referral to the House Children and Families Committee on May 12, 2023, with no indication it passed before the 2023 session ended.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws